Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Residual”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00534989
What this trial is testing

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
King Faisal Specialist Hospital & Research Center 10
Not applicableEnded earlyNCT02328664
What this trial is testing

SCar-biopsies After Malignant Colorectal Polypectomy of Uncertain RAdicality

Who this might be right for
Colorectal Cancer
Dr. Frank ter Borg MD PhD 246
Not applicableStudy completedNCT00819143
What this trial is testing

Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease

Who this might be right for
Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 3
Not applicableEnrolling By InvitationNCT06102889
What this trial is testing

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES

Who this might be right for
Pancreatic Adenocarcinoma
Karolinska University Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT02954874
What this trial is testing

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 1,195
Not applicableUnknownNCT02400970
What this trial is testing

Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors

Who this might be right for
Minimal Residual DiseaseFertility Preservation
University Hospital, Clermont-Ferrand 40
Not applicableUnknownNCT05697913
What this trial is testing

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma
Hospital Galdakao-Usansolo 66
Large-scale testing (Phase 3)Looking for participantsNCT05929222
What this trial is testing

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 190
Early research (Phase 1)Ended earlyNCT05001451
What this trial is testing

Study of GDX012 in Patients With MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
GammaDelta Therapeutics Limited 3
Not applicableNot Yet RecruitingNCT06651203
What this trial is testing

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

Who this might be right for
Mycosis Fungoides/Sezary SyndromeCutaneous T Cell Lymphoma
Assistance Publique - Hôpitaux de Paris 460
Post-approval studies (Phase 4)WithdrawnNCT02379754
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Large-scale testing (Phase 3)Looking for participantsNCT06332274
What this trial is testing

TislelizUMaB in canceR Patients With molEcuLar residuaL Disease

Who this might be right for
CancerLung CancerColo-rectal Cancer+2 more
Gustave Roussy, Cancer Campus, Grand Paris 717
Testing effectiveness (Phase 2)Looking for participantsNCT05343013
What this trial is testing

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 25
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT02349178
What this trial is testing

Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid Leukemia
Medical College of Wisconsin 6
Testing effectiveness (Phase 2)Looking for participantsNCT05872724
What this trial is testing

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

Who this might be right for
Cervical Cancer
Suzhou Municipal Hospital 32
Testing effectiveness (Phase 2)Ended earlyNCT03537599
What this trial is testing

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Who this might be right for
Minimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more
Sumithira Vasu 4
Not applicableUnknownNCT06267144
What this trial is testing

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 20
Not applicableStudy completedNCT06000306
What this trial is testing

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Who this might be right for
Measurable Residual Disease
Zhejiang University 192
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Next Page